Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

When reviewing the protocols for managing neutropenia, one might conclude that the presence of CIN must negatively affect QOL. For example, to reduce the risk for infection, patients with ...